UPC (Universe Pharmaceuticals) DeferredTaxAndRevenue: $0.04 Mil (As of Sep. 2025)


UPC Universe Pharmaceuticals Inc UPC
62 GF Score
Price $5.52
GF Value $5.20
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals DeferredTaxAndRevenue?

Universe Pharmaceuticals UPC -8.85% 62 DeferredTaxAndRevenue is $0.04 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 62/100 and a GF Value™ of $5.20 (Fairly Valued). The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Universe Pharmaceuticals's current deferred tax and revenue for the quarter that ended in Sep. 2025 was $0.04 Mil.

Universe Pharmaceuticals DeferredTaxAndRevenue Related Terms

Universe Pharmaceuticals DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals DeferredTaxAndRevenue Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.04

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.04
UPC
62GF Score
Universe Pharmaceuticals Inc UPC
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.04 Mil mean?
Universe Pharmaceuticals (UPC) has a DeferredTaxAndRevenue of $0.04 Mil as of Sep. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Universe Pharmaceuticals.
Is Universe Pharmaceuticals' DeferredTaxAndRevenue too high?
Universe Pharmaceuticals' current DeferredTaxAndRevenue is $0.04 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' DeferredTaxAndRevenue compare to CPMD and SHPH?
Universe Pharmaceuticals' DeferredTaxAndRevenue of $0.04 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Universe Pharmaceuticals. Universe Pharmaceuticals's current DeferredTaxAndRevenue is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Fairly Valued. The stock's GF Value™ is $5.20, compared to a current price of $5.52 — trading 6.2% above its estimated fair value. The current DeferredTaxAndRevenue is $0.04 Mil. Universe Pharmaceuticals' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current DeferredTaxAndRevenue is $0.04 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $5.52 is trading 6.2% above its estimated GF Value™ of $5.20. GuruFocus considers Universe Pharmaceuticals to be Fairly Valued.

Key valuation signals for UPC:

  • DeferredTaxAndRevenue: $0.04 Mil
  • GF Value™: $5.20 vs. price of $5.52 (6.2% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
62GF Score

Get the complete analysis for UPC

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.52
Price
$5.20
GF Value